Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes could be effective for improving skin health and treating skin diseases.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

SH-340 may improve skin barrier and help treat atopic dermatitis.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

A Cavalier King Charles Spaniel had both uveodermatological syndrome and alopecia areata, and treatment with ciclosporin helped regrow hair.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Alopecia areata is decreasing globally, affects more females, and is linked to anxiety and atopic dermatitis, especially in children.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

Wearing a hijab changes the common bacteria and fungi on the scalp, possibly affecting skin health.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.